Drugs / CVac
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02310971 | Feb → Mar 2015 | digestive system carcinoma | Prima BioMed Ltd | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CVac | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02310971 ↗ |
| Modality | Cell therapy | “an investigational cell therapy” NCT02310971 ↗ |